About 126,000 results
Open links in new tab
AstraZeneca and Daiichi Sankyo report data from Phase III breast …
Datopotamab deruxtecan final overall survival results reported in ...
meaningful progression-free survival improvement - AstraZeneca
Press Releases - Daiichi Sankyo US
Datopotamab deruxtecan showed clinically meaningful
AZ, Daiichi's Enhertu cleared by FDA in wide range of tumors
Daiichi Sankyo-AstraZeneca’s ENHERTU gains FDA BTD status
AstraZeneca's experimental drug disappoints in breast cancer …
A pharma partnership that brought a breakthrough in breast cancer